ProCE Banner Activity

Targeting AKT in HER2-Negative Breast Cancer: Implications for Future Clinical Practice

Slideset

Download these slides reviewing data on investigational agents targeting AKT in HER2-negative metastatic breast cancer.

Released: July 27, 2023

Share

Faculty

Joyce O'Shaughnessy

Joyce O'Shaughnessy, MD

Celebrating Women Chair in Breast Cancer Research
Director, Breast Cancer Research Program
Baylor University Medical Center
Medical Oncologist
Texas Oncology/ Baylor Charles A. Sammons Cancer Center
Dallas, Texas

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca